Furthermore, the knockdown of KDM4C sensitized hepatoma cancer cells to cisplatin [92], and the knockdown of KDM4A effectively sensitized resistant ovarian cancer cells to cisplatin [190]. Here, KDM4C is linked to ovarian cancer.